Prelude Capital Management, LLC Portfolio Holdings

Prelude Capital Management, LLC

  • $1.5 Billion
  • Q4 2024

Prelude Capital Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.5 Billion distributed in 1179 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr Gold Trust with a value of $17.2M, Nvidia Corp with a value of $17.1M, Amazon Com Inc with a value of $16.3M, Smartsheet Inc with a value of $14M, and Tesla, Inc. with a value of $13M.

Examining the 13F form we can see an decrease of $72.8M in the current position value, from $1.57B to 1.5B.

Prelude Capital Management, LLC is based out at New York, NY

Below you can find more details about Prelude Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.5 Billion
ETFs: $315 Million
Technology: $272 Million
Consumer Cyclical: $188 Million
Healthcare: $122 Million
Financial Services: $115 Million
Communication Services: $105 Million
Industrials: $103 Million
Real Estate: $70.5 Million
Other: $207 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Ge Vernova Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Moneylion Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Knife River Corp
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 47.02%
Bw Lpg LTD
-
$0 0.0% of portfolio
-
Q4 2024 New
Xperi Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 28.08%
Aptiv PLC
-
$0 0.0% of portfolio
-
Q4 2024 New
Universal Stainless & Alloy
-
$0 0.0% of portfolio
-
Q4 2024 New
Cava Group Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Rubrik Inc.
-
$0 0.0% of portfolio
-
Q4 2024 New
Arm Holdings PLC
-
$0 0.0% of portfolio
-
Q4 2024 New
Perimeter Solutions Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q4 2024 New
Colombier Acquisition Corp I
-
$0 0.0% of portfolio
-
Q4 2024 New
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 199.67%
Phinia Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 3.45%
Ncr Atleos Corporation
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 46.43%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q4 2024 Added 95.67%
Primo Brands Corporation
-
$0 0.0% of portfolio
-
Q4 2024 New
Hafnia LTD
-
$0 0.0% of portfolio
-
Q4 2024 New
Coya Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Ftai Aviation LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 40.35%
Vyne Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 8.82%
Ramaco Res Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 75.93%
Aris Mng Corp
-
$0 0.0% of portfolio
-
Q4 2024 Added 320.4%
Gen Restaurent Group
-
$0 0.0% of portfolio
-
Q4 2024 New
Serve Robotics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Frontline PLC
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 68.37%
Irsa Inversiones Y Rep S A
-
$0 0.0% of portfolio
-
Q4 2024 New
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 104.54%
Optinose Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
-
$0 0.0% of portfolio
-
Q4 2024 New
Npk International Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 44.05%
-
$0 0.0% of portfolio
-
Q4 2024 New
Amplify ETF Tr
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 23.94%
Metagenomi Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 156.09%
Inseego Corp
-
$0 0.0% of portfolio
-
Q4 2024 Added 4.27%
Bioage Labs Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$0
$0 0.0% of portfolio
14,586
Q4 2024 Reduced 46.97%
Vizsla Silver Corp
-
$0 0.0% of portfolio
-
Q4 2024 Added 25.69%
Leap Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$32.4M
$73,000 0.0% of portfolio
35,820
Q1 2024 Reduced 38.35%
$0
$70,000 0.0% of portfolio
24,328
Q4 2024 Reduced 27.66%
Gran Tierra Energy Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$56.4M
$73,000 0.0% of portfolio
51,357
Q4 2024 Reduced 85.92%
$168M
$73,000 0.0% of portfolio
32,170
Q4 2024 New
$181M
$73,000 0.0% of portfolio
16,200
Q4 2024 Reduced 52.21%
$250M
$72,000 0.0% of portfolio
15,212
Q4 2024 Reduced 14.07%
$403M
$71,000 0.0% of portfolio
14,200
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 1,179
  • Current Value $1.5 Billion
  • Prior Value $1.57 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 369 stocks
  • Additional Purchases 274 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 360 stocks
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email